IDENTIFICATION OF PERSONALIZED ACTIVE AGENTS IN PEDIATRIC GLIOMAS THROUGH HIGH-THROUGHPUT DRUG SCREENING IN MATCHING PAIRS OF PATIENT DERIVED ORTHOTOPIC XENOGRAFT (PDOX) NEUROSPHERE AND MONOLAYER CELLS

被引：0
|
作者：
Qi, Lin [1 ]
Du, Yuchen [1 ]
Bae, Goeum [2 ]
Kogiso, Mari [1 ]
Braun, Frank [1 ]
Lindsay, Holly [1 ]
Zhang, Huiyuan [1 ]
Injac, Sarah [1 ]
Baxter, Patricia [1 ]
Su, Jack [1 ]
Mancini, Michael [3 ]
Hampton, Oliver [4 ]
Parsons, William [1 ]
Chintagumpala, Murali [1 ]
Stephan, Clifford [2 ]
Davies, Peter [2 ]
Li, Xiao-Nan [1 ]
机构：
[1] Texas Childrens Canc Ctr, Dept Pediat, Houston, TX USA
[2] Texas A&M Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[4] Baylor Coll Med, Human Genome Ctr, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HGG-14
引用
收藏
页码：25 / 25
页数：1
相关论文
共 14 条
  • [1] IDENTIFICATION OF PERSONALIZED ACTIVE AGENTS IN PEDIATRIC GLIOMAS THROUGH HIGH-THROUGHPUT DRUG SCREENING IN MATCHING PAIRS OF PATIENT DERIVED ORTHOTOPIC XENOGRAFT (PDOX) NEUROSPHERE AND MONOLAYER CELLS
    Qi, Lin
    Du, Yuchen
    Bae, Goeun
    Kogiso, Mari
    Braun, Frank
    Lindsay, Holly
    Zhang, Huiyuan
    Zhao, Sibo
    Injac, Sarah
    Baxter, Patricia
    Su, Jack
    Mancini, Michael
    Hampton, Oliver
    Parsons, William
    Chintagumpala, Murali
    Stephan, Clifford
    Davies, Peter
    Li, Xiao-Nan
    NEURO-ONCOLOGY, 2017, 19 : 196 - 196
  • [2] Identification of personalized active agents in pediatric gliomas through high-throughput drug screening in matching pairs of patient derived orthotopic xenograft (PDOX) neurosphere and monolayer cells
    Qi, Lin
    Du, Yuchen
    Kogiso, Mari
    Bae, Goeun
    Braun, Frank
    Lindsay, Holly
    Zhang, Huiyuan
    Zhao, Sibo
    Injac, Sarah
    Baxter, Patricia
    Su, Jack
    Mancini, Michael
    Hampton, Oliver
    Parsons, William
    Chintagumpala, Murali
    Stephan, Clifford
    Davies, Peter
    Li, Xiao-Nan
    Li, Xiao-Nan
    CANCER RESEARCH, 2017, 77
  • [3] Identification of personalized active agents in pediatric medulloblastoma through high-throughput drug screening in matching pairs of patient derived orthotopic xenograft neurosphere and monolayer cells
    Qi, Lin
    Du, Yuchen
    Bae, Goeun
    Mari, Mari
    Braun, Frank
    Lindsay, Holly
    Zhang, Huiyuan
    Zhao, Sibo
    Injac, Sarah
    Baxter, Patricia
    Su, Jack
    Mancini, Michael
    Hampton, Oliver
    Parsons, William
    Chintagumpala, Mural
    Stephan, Clifford
    Davies, Peter
    Li, Xiaonan
    CANCER RESEARCH, 2018, 78 (13)
  • [4] IDENTIFICATION OF EFFICACIOUS AGENTS IN PEDIATRIC EPENDYMOMA THROUGH HIGH-THROUGHPUT DRUG SCREENING IN MATCHING PAIRS OF PATIENT DERIVED ORTHOTOPIC XENOGRAFT (PDOX) NEUROSPHERE AND MONOLAYER CELLS
    Guo, Lei
    Zhang, Huiyuan
    Zhao, Sibo
    Du, Yuchen
    Qi, Lin
    Bae, Goeun
    Braun, Frank
    Kogiso, Mari
    Lindsay, Holly
    Injac, Sarah
    Baxter, Patricia
    Su, Jack
    Stephan, Clifford
    Davies, Peter
    Li, Xiao-Nan
    NEURO-ONCOLOGY, 2017, 19 : 262 - 262
  • [5] RACIAL/ETHNIC DIFFERENCES OF PEDIATRIC BRAIN TUMORS IN PATIENT DERIVED ORTHOTOPIC XENOGRAFT (PDOX) MODEL DEVELOPMENT AND DRUG RESPONSES DETECTED BY HIGH-THROUGHPUT DRUG SCREENING
    Abdallah, Aalaa
    Du, Yuchen
    Li, Xiao-Nan
    Qi, Lin
    Kogiso, Mari
    Braun, Frank
    NEURO-ONCOLOGY, 2023, 25
  • [6] Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now
    Langenberg, K.
    Kholosy, W.
    Schild, L.
    Breunis, W.
    Koopmans, B.
    Koster, J.
    Goemans, B.
    Zwaan, C. M.
    Molenaar, J.
    Dolman, E.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S432 - S432
  • [7] Integration of high-throughput drug screening on patient-derived organdies into pediatric precision medicine programs: The future is now!
    Langenberg, Karin
    Dolman, Emmy
    Molenaar, Jan
    CANCER RESEARCH, 2020, 80 (14) : 64 - 64
  • [8] Patient-derived pluripotent stem cells: an in vitro model for neuromuscular diseases and high-throughput drug screening
    Benichou, S. Ait
    Martineau, L.
    Chahine, M.
    Marquette, P.
    Maziade, M.
    Leblanc, A.
    Puymirat, J.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S213 - S213
  • [9] Characterization and High-Throughput Drug Screening of a Cardiomyopathy Using Cardiomyocytes From Patient-Derived Induced Pluripotent Stem Cells
    Rowland, Teisha J.
    Hashem, Sherin I.
    Jones, Kenneth L.
    Adler, Eric D.
    LaBarbera, Daniel V.
    Mestroni, Luisa
    Taylor, Matthew R.
    CIRCULATION, 2016, 134
  • [10] Characterization and High-Throughput Drug Screening of a Cardiomyopathy Using Cardiomyocytes From Patient-Derived Induced Pluripotent Stem Cells
    Rowland, Teisha J.
    Hashem, Sherin I.
    Jones, Kenneth L.
    Adler, Eric D.
    LaBarbera, Daniel V.
    Mestroni, Luisa
    Taylor, Matthew R.
    CIRCULATION, 2016, 134
12